MAP2K7 and malignant colon neoplasm: WNT signaling was enriched in trametinib treated tumors, consistent with the finding that MEK inhibition increases WNT signaling in colon cancer cells serving as a possible escape mechanism for colon cancer cells in the face of MEK inhibition33.